AI brief of an SEC Form 8-K · Dentsply Sirona (XRAY)

Dentsply Sirona posts $427 million Q3 loss, cuts 2025 outlook and CFO departs

Negative Impact 4 of 5 earnings Written later

Dentsply Sirona reported third-quarter 2025 net sales of $904 million, down 5.0% from a year earlier, and a GAAP net loss attributable to the company of $427 million, or $2.14 per share, which included a $263 million non-cash impairment charge. The company revised its 2025 outlook to net sales of $3.6 billion to $3.7 billion and adjusted EPS of about $1.60, and said CFO Matt Garth has departed, which shareholders should weigh against the company's Return-to-Growth plan.

Key points

  • Q3 2025 net sales were $904 million, down 5.0% as reported and down 8.0% in constant currency.
  • GAAP net loss attributable to Dentsply Sirona was $427 million ($2.14 per share), versus a $494 million loss ($2.46 per share) a year earlier; adjusted EPS was $0.37 versus $0.50.
  • Revised 2025 outlook: net sales of $3.6 billion to $3.7 billion and adjusted EPS of about $1.60.
  • CFO Matt Garth departed; Dustin Shields was named Chief Transformation Officer effective December 1, 2025.

The filing

CompanyDentsply Sirona (XRAY)
Form8-K, current report
Filed with the SECNov 6, 2025, 8:15 AM ET
Accession number0000818479-25-000254

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.